[DIV28SUPER] NIDA Neuroscience Update, December 22, 2010

Table of Contents

I. Proposed Institute for Substance Use, Abuse, & Addiction

 

II. RFA-DA-11-004. Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence (STTR [R41]) Applications

Receipt date:  January 13, 2011

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-004.html

 

III. Collaborative Research in Computational Neuroscience (CRCNS) Innovative Approaches to Science and Engineering Research on Brain Function [R01]  http://www.nsf.gov/pubs/2011/nsf11505/nsf11505.htm

Receipt Dates: February 16, 2011, November 2, 2011 and November 2, 2012

 

IV. PAR-11-032 Methods and Approaches for Detection of Gene-Environment Interactions in Human Disease (R21) (http://grants.nih.gov/grants/guide/pa-files/PAR-11-032.html)

Receipt date: February 3, 2011

 

V. PA-11-009 Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) (http://grants.nih.gov/grants/guide/pa-files/PA-11-009.html)

Receipt dates: Standard dates apply http://grants1.nih.gov/grants/funding/submissionschedule.htm 

 

VI. PA-11-026 Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01) (http://grants.nih.gov/grants/guide/pa-files/PA-11-026.html)

Receipt dates: Standard dates apply http://grants1.nih.gov/grants/funding/submissionschedule.htm 

 

VII. PA-11-033 Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction

(R01) (http://grants.nih.gov/grants/guide/pa-files/PA-11-033.html)

(R21) (http://grants.nih.gov/grants/guide/pa-files/PA-11-034.html)

(R03) (http://grants.nih.gov/grants/guide/pa-files/PA-11-035.html)

Receipt dates: Standard dates apply http://grants1.nih.gov/grants/funding/submissionschedule.htm 

 

VIII. PA-11-027 The Development of Frontal Cortex and Limbic System and Their Roles in Drug Abuse (R01) (http://grants.nih.gov/grants/guide/pa-files/PA-11-027.html)

Receipt dates: Standard dates apply http://grants1.nih.gov/grants/funding/submissionschedule.htm 

 

IX.  PA-11-047  Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence

(R01) (http://grants.nih.gov/grants/guide/pa-files/PA-11-047.html)

(R21)  (http://grants.nih.gov/grants/guide/pa-files/PA-11-048.html

(R03)  http://grants.nih.gov/grants/guide/pa-files/PA-11-049.html

 

X. RFA: Support Opportunity for Addiction Research (SOAR) for New Investigators (R03)

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-010.html

Letter of Intent Due Date:  January 3, 2011

Receipt Date: February 2, 2011

Receipt dates: Standard dates apply http://grants1.nih.gov/grants/funding/submissionschedule.htm 

 

 

 

I. Proposed Institute for Substance Use, Abuse, & Addiction

On Nov. 15, 2010, the National Institutes of Health (NIH) received the formal recommendation from the Scientific Management Review Board (SMRB) to create a new Institute that would focus on substance use, abuse, and addiction research and related public health initiatives. This proposed Institute would integrate the relevant research portfolios from the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and other NIH Institutes and Centers. The NIH agrees that the proposed realignment of NIH programs into a single, new Institute devoted to such research makes scientific sense and would enhance our efforts to address the substance abuse and addiction problems that take such a terrible toll on our society. For more information go to http://feedback.nih.gov/index.php/category/suaa/.  To submit questions about the proposed merger go to http://feedback.nih.gov/index.php/suaa/suaa-questions/ and to post comments go to http://feedback.nih.gov/index.php/suaa/suaa-comments/

 

II.  RFA-DA-11-004. Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence (STTR [R41])

Receipt date:  January 13, 2011

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-004.html

The National Institute on Drug Abuse (NIDA) solicits applications for the development of novel treatments for nicotine dependence.  Up to $1.5M has been set aside to fund 4 or more meritorious small business technology transfer phase I (STTR) 1-year grants in FY2011!  Awardees would subsequently be eligible to apply for Phase II funding. Phase II projects can be supported at a level of ~$1M over two years and be competitively renewed. 

The STTR program ( http://grants.nih.gov/grants/funding/sbirsttr_programs.htm) is designed to fund collaborative projects between small businesses and non-profit research institutions. Its objectives are to move ideas from the laboratory into the marketplace and foster high-tech economic development. Because NIDA recognizes the potential complexity of establishing business-academic collaborations, NIDA staff will help cultivate these relationships for potential applicants.  

 

III. Collaborative Research in Computational Neuroscience (CRCNS) Innovative Approaches to Science and Engineering Research on Brain Function [R01]  http://www.nsf.gov/pubs/2011/nsf11505/nsf11505.htm

Receipt Dates: February 16, 2011, November 2, 2011 and November 2, 2012

 

The Collaborative Research in Computational Neuroscience (CRCNS) research grant initiative has just been re-issued from seven National Science Foundation (NSF) Directorates and Offices (DOs), and nine participating National Institutes of Health (NIH) Institutes and Centers (ICs) including NIDA.  The German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF http://www.bmbf.de/) is a formal partner and CRCNS is also affiliated with the NIH Blueprint for Neuroscience Research (http://neuroscienceblueprint.nih.gov). 

Through the CRCNS program, participating NSF DOs, NIH ICs and BMBF support innovative interdisciplinary collaborative research to make significant advances in the understanding of structures and functions of the nervous system, mechanisms underlying nervous system disorders, and computational strategies used by the nervous system.  Three general perspectives for proposals will be considered in response to this solicitation:

Research proposals - describing new collaborative research projects

US-German Research Proposals - describing international collaborative research projects to be funded in parallel by US and German agencies

Data Sharing Proposals - enable sharing of data and other resources

The CRCNS announcement is released under NSF 11-505. For more details including how to apply and for program contacts please go to the full announcement: http://www.nsf.gov/pubs/2011/nsf11505/nsf11505.htm

 

IV. PAR-11-032 Methods and Approaches for Detection of Gene-Environment Interactions in Human Disease (R21) (http://grants.nih.gov/grants/guide/pa-files/PAR-11-032.html)

Receipt date: February 3, 2011

 

This FOA issued by NIEHS, National Institutes of Health, encourages grant applications from institutions/organizations to develop and test innovative statistical and bioinformatics methods and analytical strategies and study designs for identifying gene-environment interactions for complex human diseases.  The objectives of this FOA are to further advance the understanding of gene-environment interplay in complex human disease by 1) the development and validation of algorithms and new statistical and computational approaches and study designs and/or 2) the development and application of bioinformatics software for gene-environment analysis of existing human populations.   

 

V. PA-11-009 Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23)(http://grants.nih.gov/grants/guide/pa-files/PA-11-009.html)

Receipt dates: Standard dates apply http://grants1.nih.gov/grants/funding/submissionschedule.htm 

 

The purpose of this Mentored Patient-Oriented Research Career Development Award (K23) is to provide salary and “protected time” (up to five years for this award) to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research.  Each Research Career Development Award must be tailored to meet the individual needs of the candidate.  The Translational Scholar Awards in Pharmacogenomics and Personalized Medicine program is intended to address the scarcity of investigators cross-trained in both clinical research core competencies and modern methods required to address pharmacogenomics research problems in patient populations.  Dual mentors from the Clinical and Translational Science Awards consortium and the Pharmacogenomics Research Network are required.

 

VI. PA-11-026 Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01) (http://grants.nih.gov/grants/guide/pa-files/PA-11-026.html)

Receipt dates: Standard dates apply http://grants1.nih.gov/grants/funding/submissionschedule.htm 

 

This FOA encourages applications for research projects that identify and/or validate chromosomal loci and variations in genes that are associated with vulnerability to addiction and that inform the likelihood of responsiveness to treatment.  Applications that propose to examine intermediate phenotypes or endophenotypes to assess the molecular genetics of drug addiction, addiction vulnerability and/or their associated co-morbidities and how they are related to drug addiction are especially encouraged.  Also encouraged are genetic as well as computational and large-scale genomic approaches, which may include but are not limited to linkage, linkage disequilibrium, case-control or family-based studies, and integration of data from other databases that may supplement substance abuse genetics and genomics data.  Data may be collected from the general population, special populations, recent admixed populations, and/or animal models.  Investigators are encouraged to include, as a component of their project and as appropriate, gene x gene interactions, gene x environment interactions, gene x environment x development interactions, pharmacogenetics, and non-human models.

 

VII. PA-11-033 Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction

(R01) (http://grants.nih.gov/grants/guide/pa-files/PA-11-033.html)

(R21) (http://grants.nih.gov/grants/guide/pa-files/PA-11-034.html)

(R03) (http://grants.nih.gov/grants/guide/pa-files/PA-11-035.html)

Receipt dates: Standard dates apply http://grants1.nih.gov/grants/funding/submissionschedule.htm 

 

Purpose Genetic and genomic studies have identified genes and gene variants that potentially modulate the fundamental biological mechanisms underpinning addictive processes.  Discovery of these genes/variants, while extremely valuable, is only a first step in understanding molecular mechanisms of addiction.  This Funding Opportunity Announcement encourages basic functional genomic research in two areas:  1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction.

 

VIII. PA-11-027 The Development of Frontal Cortex and Limbic System and Their Roles in Drug Abuse (R01) (http://grants.nih.gov/grants/guide/pa-files/PA-11-027.html)

Receipt dates: Standard dates apply http://grants1.nih.gov/grants/funding/submissionschedule.htm 

 

This Funding Opportunity Announcement (FOA) issued by NIDA encourages Research Project Grant (R01) applications from institutions/organizations that propose to study the development of the frontal and prefrontal cortices, together with the subcortical areas of the limbic system, that play significant roles in mediating emotional and motivated behavior.  This initiative is designed to support the basic neuroscience research into the fundamental mechanisms of development of the frontal and prefrontal cortices, as well as the midbrain and basal forebrain structures that mediate a number of functions related to drug abuse and psychiatric disorders including:  the euphoric properties of drugs, actions of psychotherapeutic agents, and memory, cognitive and emotional functions.  An additional major goal of this initiative is to understand how exposure to drugs of abuse affects the cellular and molecular mechanisms underlying nervous system development of circuits implicated in drug reward and addiction. 

 

IX.  PA-11-047  Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence

(R01) (http://grants.nih.gov/grants/guide/pa-files/PA-11-047.html)

(R21)  (http://grants.nih.gov/grants/guide/pa-files/PA-11-048.html

(R03)  http://grants.nih.gov/grants/guide/pa-files/PA-11-049.html

Receipt dates: Standard dates apply http://grants1.nih.gov/grants/funding/submissionschedule.htm 

 

The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA) is to advance research on male-female differences in drug and alcohol abuse and addiction and on factors specific to women.  Both human research and animal model studies are sought.   

 

X. RFA: Support Opportunity for Addiction Research (SOAR) for New Investigators (R03)

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-010.html

Letter of Intent Due Date:  January 3, 2011

Receipt Date: February 2, 2011

 

The National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) are interested in receiving applications to supplement new investigators who have, or have a commitment of support to conduct research in basic or clinical alcohol or drug abuse research from funding sources other than NIH (e.g. private foundation).  In addition, those applicants currently supported to conduct research on psychiatric disorders that are often found to be co-morbid with substance abuse, are also eligible to apply to SOAR for the purpose of adding a substance or alcohol abuse research component to their on-going research.  It is hoped that the SOAR program will facilitate ongoing supported substance abuse and co-morbidity research among entry-level new investigators.  This Funding Opportunity Announcement (FOA) is intended to support new investigators’ on-going basic or clinical alcohol, drug abuse and/or related co-morbidity research. The primary goal of this Support Opportunity for Addiction Research (SOAR) is for new investigators to leverage existing research programs in order to strengthen, possibly expand, and/or further develop alcohol, drug abuse, and co-morbidity research.   For more details see: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-010.html

   

-----

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services

TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email

- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309

 

[DIV28SUPER] NCRR's future

A potential concern to some research programs of div28 members

---------- Forwarded message ----------
From: Ken Boschert <kboschert@gmail.com>
Date: Mon, Dec 20, 2010 at 10:14 AM
Subject: Re: [COMPMED] NCRR's future
To: COMPMED@listserv.aalas.org


I'm resending due to the footer that our campus email system automatically
adds to the bottom of each message about privacy, etc.  You can feel free to
recirculate this message.
Ken

-----Original Message-----
From: (COMPMED) Comparative Medicine List
[mailto:COMPMED@LISTSERV.AALAS.ORG] On Behalf Of Boschert, Ken
Sent: Sunday, December 19, 2010 11:32 PM
To: COMPMED@LISTSERV.AALAS.ORG
Subject: [COMPMED] FW: NCRR's future

Forwarded by request....kb
From: Linda C. Cork [mailto:lcork@stanford.edu]
Sent: Saturday, December 18, 2010 6:42 PM
Subject: NCRR's future

I am not sure how many folks are aware of the jeopardy in which NCRR- the
sole funding for Comparative Medicine at NIH- has been placed by the
creation of the Center for Translational Medicine by the Scientific
Management Review Board (SMRB). Because there is a limit on the number of
Centers NIH can have, the creation of this new Center meant that it would
incorporate the Clinical Research Centers which were a part of NCRR. BUT,
within NCRR there were many other programs that spanned NIH and did not fit
within a categorical Institute's mission: that was the reason the Division
of Research Resources, now National Center for Research Resources, was
created originally. NCRR funds minority program, ALL the T-32 and T35
training programs for veterinarians in lab animal medicine and veterinary
pathology, ALL the facilities improvement grants, the Primate Centers, many
of the Stock Resources (Jackson Lab, mutant mice, rat resource,
gnotobiotics, Zebrafish, Drosophila, Stem Cell, C. elegans, etc, etc.)
Apparently, when the plans were made to create this new Center little
analysis was made beforehand of where these other units in NCRR would go,
and many might be dismantled entirely.  It is essential that they hear from
the lab animal community.
 The NCRR task force has begun meetings with the staff of NCRR to formulate
plans for implementation of the SMRB recommendation. Although it still seems
that the intent is to dismantle NCRR, some members of the taskforce are
apparently asking questions that suggest that there may be some support for
NOT doing so. There is an opportunity to comment via a new web site, so
members of the research community who want to provide input to this process
need to know that there is a NIH new web site that is soliciting input on
the proposals of the SMRB: http://feedback.nih.gov/  One member of the
office of the director commented that there were not many comments on this
so the community "must not be very interested." The web site has 2 issues
for comment; the one you want is Proposed National Center for Advancing
Translational Sciences<http://feedback.nih.gov/index.php/category/ncats/>.
If you look to the left, click on "Comments". Type your comment in the box.

Please alert members of your NCRR stakeholder community (including Deans and
senior administrators) to visit this site and make their thoughts known.
They should do this even if they have already submitted letters to the SMRB
(which are now posted at http://smrb.od.nih.gov/meetings/index.asp?year=2010
). If enough voices are heard on that comment site perhaps we will have some
impact on those charged with recommending changes.
This process is still moving very fast so it is very important to post
comments before Christmas if possible.

Linda C. Cork, D.V.M., Ph.D.
Professor

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

Re: [DIV28M] Substance Abuse Tests

I am interested in obtaining a listing of the most reliable and valid standardized substance abuse tests for adolescents and adults.

Thanks in advance,
Bill Hosmer

__________________ Div28m@lists.apa.org ___________________
restricted to APA members subscribers corner: http://lists.apa.org

[DIV28SUPER] Update on Substance Use Abuse and Addiction (SUAA) Task Force

At today’s meeting of the NIH Advisory Committee to the Director, NIH Deputy Director, Dr. Larry Tabak discussed the steps for moving forward with his SUAA Task Force.  Task Force members (see below) were selected from among senior NIH staff specifically because they had no professional investment (“skin in the game”) in SUAA-related research.  They will be performing an analysis to identify SUAA activities across the NIH for possible inclusion in a new SUAA Institute as well as SUAA activities within NIAAA and NIDA that could potentially be moved to other relevant ICs. To assist in those efforts, content experts from the staffs of NIAAA, NIDA, NCI, NIMH, NICHD, and NIDDK have been identified by their respective Institute Directors to aid in the portfolio analysis.

  

Task Force members include (Institute/Office affiliation):

Dr.Michael Gottesman, (OD/DIR)

Dr. Eric Green – (NHGRI)

Dr. Pamela McInnes – (NIDCR)

Dr. Roderic Pettigrew – (NIBIB)

Dr. Carl Roth – (NHLBI)

Dr. Kathy Zoon – (NIAID)

 

A website featuring the latest developments on this Task Force is expected to go live later this afternoon at http://feedback.nih.gov/

That site will also serve as a repository for information and a feedback portal on the newly proposed National Center for Advancing Translational Sciences (which has already been posted).

 

46 organizations endorsed the attached letter from APA providing suggestions to Dr. Collins as the Task Force begins its review.  Science Government Relations Office staff will continue to look for opportunities to inform this process.

 

Regards,

-geoff

 

Geoff Mumford, PhD| Associate Executive Director Government Relations Office Science Directorate American Psychological Association 750 First Street NE, Washington, DC 20002-4242 Tel: (202) 336-6067|  Fax: (202) 336-6063 email: gmumford@apa.org | www.apa.org

 

[DIV28M] Scientist Spotlight Series: December

Hello,

Please enjoy this December edition of the Scientist Spotlight!

Happy Holidays!
Sarah and Kelly

--------------------------------------

Scientist Spotlight is a monthly series that asks senior and mid-level scientists to provide information on how they choose to balance work and life responsibilities. This column is in response to an overwhelming request from Early Career Psychologists that more information (and assistance) in learning how to balance work and life be made available.  We are hopeful that by reading how different scientists balance work and life goals and responsibilities, graduate students and Early Career Psychologists will be better prepared to develop methods for being successful in science while still meeting personal life goals. Overall, we hope you find this series useful and enjoyable!

Please contact Kelly Dunn (kdunn9@jhmi.edu) or Sarah Tragesser (stragesser@tricity.wsu.edu) to nominate someone to be highlighted in this series.

--
Kelly Dunn, Ph.D.
NIDA Postdoctoral Fellow
Center for Learning and Health
Johns Hopkins University School of Medicine
5200 Eastern Avenue, Suite 142 West
Baltimore, MD 21224
Phone: (410) 550-5370
Fax: (410) 550-7495
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28m@lists.apa.org
restricted to APA members list archive
twitter: @apadiv28

[DIV28SUPER] FDA Study of Graphic Cigarette Warning Labels Posted Today on Regulations.gov

FDA Study of Graphic Cigarette Warning Labels Posted Today on Regulations.gov

FDA Experimental Study of Graphic Cigarette Warning Labels, Final Results Report, was posted on Regulations.gov today. The Report and appendices are available at:  http://www.regulations.gov/search/Regs/home.html#documentDetail?R=0900006480bad0e1.

For more information on the Proposed Cigarette Product Warning Labels, visit www.fda.gov/cigarettewarnings.

  

You are subscribed to FDA Tobacco Products Email Updates.  If you have questions, please email AskCTP@fda.hhs.gov or call 1-877-CTP-1373.   Follow us on Twitter @FDATobacco.

 

 

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@govdelivery.com
• Other inquiries? webmail@oc.fda.gov

 

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420

 

[DIV28SUPER] Postdoctoral Fellowship in Addiction Research at the University of Southern California

Postdoctoral Fellowship, Addiction Research, University of Southern California Keck School of Medicine

Postdoctoral fellowships in addiction research are available at the USC Health, Emotion, & Addiction Laboratory (HEAL) in Los Angeles, CA.   Fellows will have the opportunity to be involved in NIH-funded research examining the role of psychosocial and biobehavioral factors in the etiology of tobacco, alcohol, and drug addiction.  The position provides ample opportunities to participate in publishing, grant writing, and career development activities as well as mentored training in addiction research.  Candidates should have strong research training in clinical psychology, experimental psychology, human behavioral pharmacology, psychiatric epidemiology, or health behavior studies.  Applicants should also have an interest in pursuing a career in addiction research but prior research experience in this area is not required.  The USC-HEAL is housed within the Department of Preventive Medicine—Division of Health Behavior Research, which provides the opportunity to collaborate with a vibrant, multi-disciplinary group of faculty, postdocs, and graduate students.  Fellowships are funded by an NIH T32 training program.  The start date is flexible and appointments range from 2 to 3 years.  Review of applications will begin immediately and will continue until the position is filled.  Additional information can be found at http://hsc.usc.edu/~amlevent/.  Interested candidates should send an inquiry email and CV to: Adam Leventhal, Ph.D.  adam.leventhal@usc.edu

---------------------------------------------------------------------------------------
Adam Leventhal, Ph.D.
Assistant Professor of Preventive Medicine and Psychology
University of Southern California

Department of Preventive Medicine
Division of Health Behavior Research
USC Keck School of Medicine
2250 Alcazar St., CSC 240; Los Angeles, CA 90033
(P) 323-442-2732  (F) 323-442-2359
http://www-hsc.usc.edu/~amlevent/

---------------------------------------------------------------------------------------

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28SUPER] FW: Div 28 Nomination - Final Notice

Final Notice:

 

Nominations are requested for the 2011 MED Associates Brady/Schuster Award, Outstanding Dissertation Award, and Wyeth Young Psychopharmacologist Award. I have attached an announcement soliciting nominations that includes a list of previous winners. Candidates must be nominated by a Member or Fellow of Division 28. Any snail-mailed materials should be sent to: Chana Akins, Department of Psychology, University of Kentucky, Lexington, KY 40506-0044.   E-mailed materials may be sent to ckakin1@uky.edu.  (Please put "Division 28 Nomination"in the Subject line on all emails). 

 

Thank you,

Chana

 

Chana K. Akins, Ph.D.

Associate Professor

Associate Editor, Psychology of Women Quarterly

Department of Psychology

University of Kentucky

Lexington, KY 40506-0044

(859)257-1103, Fax (859)323-1979

 

[DIV28SUPER] Inwomen Meeting: Save the Date

 

	The Women’s International Group asks you to save-the-date International Conference on Women, Children, and Gender Friday, June 17, 2011, 12:00 to 17:30 Westin Hotel, Hollywood, Florida, USA Planning is underway for the 2011 InWomen conference, the second annual International Women's and Children's Health and Gender Working Group conference held in conjunction with the NIDA International Forum and the CPDD Annual Scientific Meeting. The 180 registered InWomen members have received a survey asking them to set priorities for the 2011 conference. Virtual meetings are held monthly. Those interested can visit the NIDA International Virtual Collaboratory (NIVC) or contact InWomen Chair Wendee Wechsberg, Ph.D., RTI International, wmw@rti.org. The first InWomen conference, held last year, attracted participants from 27 countries. The 2010 conference participants held nine roundtables where senior researchers and new investigators identified topics for future discussion and work; their reports are available in NIVC InWomen working group folder. At the 2010 conference, registrants also received an annotated bibliography on Key Substance Abuse Prevention and Treatment Articles Focused on Women's Issues From Around the World. This document is available to the public at http://nivc.perpich.com/groups/public/resources. If you would like know the mission and join the InWomen's network, please go to http://nivc.perpich.com and register online. Membership is free. When you fill out the registration form, be sure to select the International Women's and Children's Health and Gender Group (InWomen) from the group list at the bottom of the form. Your registration will be activated within 48 hours and you will be automatically added to a discussion list to get alerts for upcoming meetings and where the minutes from meetings are disseminated. For more information on the Virtual Collaboratory, contact JGPerpich, LLC staff: info@perpich.com.

 

 

[DIV28SUPER] Fate of NCRR

I have permission from Susan VandeWoude to forward her message sent to a comparative medicine list. The reorganization effort that is likely to restructure NIAAA and NIDA into a single institute also has proposed restructuring of NCRR. NCRR is home to the CTSA program and to the regional primate research programs.

Ron

---------- Forwarded message ----------
From: VandeWoude,Susan <Sue.Vandewoude@colostate.edu>
Date: Thu, Dec 2, 2010 at 9:01 AM
Subject: [COMPMED] Fate of NCRR
To: COMPMED@listserv.aalas.org


Dear Compmed participants:

Chris Zink (Director of Comparative Medicine Training at Johns Hopkins and
Member of the NCRR Council) agreed that I could forward the email below,
excerpted from communications among T32 training program directors.
Multiple comparative/laboratory animal medicine organizations are aware of
the potential dissolution of NCRR, and representatives from a variety of
groups will be attending the meeting on Dec 7, including ACLAM, ACVP,
Directors of T32s and T35s, AAVMC and the NCRR Council.

There are likely others on Compmed who might be interested in this
information who had not been privy to these communications.

Excerpt from Dr. Zink's email:

"The proposal by the Scientific Management Review Board (SMRB) of the
NIH, at the direct request of Francis Collins, is to pull the CTSA
program out of NCRR to form the basis for the new institute canned the
National Center for Translational Science. You can view the slide show that
explains the plan as a PDF on the NIH Director's page by clicking on
Scientific Management Review Board in the left Nav bar, then on meetings,
then on presentation. Or simply go to this link
http://smrb.od.nih.gov/meetings/...


...The AAVMC, the NCRR itself, NCRR council...and Departments of Comparative
Medicine across the country are in a frenzy
about these planned draconian changes. An announcement is planned for
December 7, at which time it is believed that the changes will be a
fait accompli....There has been no mention of what will happen to
the other programs that constitute the remaining 60% of NCRR's
portfolio. I and colleagues at the NCRR, AAVMC, Comparative Medicine
departments, and the National Primate Research Centers are deeply
concerned that the remainder of NCRR, and most particularly the
Comparative Medicine Program that funds veterinary education,
training, and research, is in jeopardy.  If NCRR's Comparative
Medicine program were to be broken up among other institutes, it would
be disastrous for the funding that sustains research resource programs
at many of our member institutions...

...The next full SMRB meeting will be held on December 7 in Building
31 on the NIH campus. I have been told that the vote on whether to
move forward with formation of the new institute will be at this Dec 7
Meeting..."

Letters have been addressed to:
Scientific Management Review Board
Office of the Director, National Institutes of Health
Building 1, Room 103
9000 Rockville Pike
Bethesda, MD 20892
smrb@mail.nih.gov

Additional information may be obtained by contacting AAVMC, ACLAM, ACVP, or
T32 training program directors.  Please forward this information to anyone
whom you feel might be interested in these developments.

Sincerely,

Sue VandeWoude, DVM
Professor of Comparative Medicine
Department of Microbiology, Immunology, Pathology
Director, Laboratory Animal Resources
Colorado State University
1619 Campus Delivery
Fort Collins CO 80523-1619
(970) 491-7162; fax: 491-0523
suev@lamar.colostate.edu



------ End of Forwarded Message

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28M] Position Announcement

THE FRANKLIN COLLEGE OF ARTS AND SCIENCES AT THE UNIVERSITY OF GEORGIA invites applications for a TENURE TRACK position at the ASSISTANT PROFESSOR level to begin August, 2011 in the DEPARTMENT OF PSYCHOLOGY. Successful candidates will have a Ph.D. in Psychology and an established research program that includes interests in the area of GENETICS AS APPLIED TO COMPLEX HEALTH-RELATED PHENOTYPES, broadly defined. We seek an outstanding scholar engaged in high impact research, regardless of specific research focus, which could include a clinical, social-personality, developmental, cognitive-neuroscience or behavioral-neuroscience focus in addition to interests in behavioral genetics or molecular genetics/epigenetics.

Successful candidates will contribute to graduate and undergraduate training and be expected to develop a nationally recognized program of research and successfully compete for extramural funding. There is strong support for building a research career at the University of Georgia. The Department of Psychology has a strong, collegial and interdisciplinary faculty that offers many opportunities for collaboration. Research collaboration across the university is further enhanced by the Center for Gene-Social Environment Transactions (C-GSET) (http://www.ibr.uga.edu/centers_groups/gene.htm) at the Institute for Behavioral Research, the Core Center of Excellence recently awarded by the National Institute on Drug Abuse (http://www.cfr.uga.edu/announcements/10), an internationally recognized genetics faculty (http://www.genetics.uga.edu), and the Bio-Imaging Research Center (http://www.uga.edu/psychology/BIRC/facilities/index.htm) in the Paul D. Coverdell Biomedical Health Sciences Building, among many active research groups at UGA.

Candidates should send a letter of application including research and teaching interests, a curriculum vitae, reprints/preprints, and arrange to have three letters of reference sent. Application can be submitted either by e-mail to: shodo@uga.edu, Attn: Contextual Genetics Search Committee, or by mail to: Chair, Contextual Genetics Search Committee, C/O Steven Beach, Ph.D., Department of Psychology, University of Georgia, Athens, GA, 30602-3013.

The Franklin College of Arts and Sciences, its many units, and the University of Georgia are committed to increasing the diversity of its faculty and students, and sustaining a work and learning environment that is inclusive. The University is an EEO/AA institution. Applications received by January 26, 2011, are assured full consideration.

-------------------------------------------------------------------------------------------------
William W. Stoops, Ph.D.
Assistant Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are
confidential and are intended solely for the addressee. The information
may also be legally privileged. This transmission is sent in trust, for
the sole purpose of delivery to the intended recipient. If you have
received this transmission in error, any use, reproduction or
dissemination of this transmission is strictly prohibited. If you are
not the intended recipient, please immediately notify the sender by
reply e-mail or at (859) 257-5383 and delete this message and its
attachments, if any.
__________________ Div28m@lists.apa.org ___________________
restricted to APA members subscribers corner: http://lists.apa.org

[DIV28SUPER] FW: Act Now! Urge Congress to Preserve the $1 Billion Increase for NIH!

Dear all

I strongly encourage you to respond to this mission-critical, time-sensitive request. As our current President has correctly and often emphasized, your personal advocacy really DOES matter, and remember that you have a PERSONAL stake in maintaining adequate NIH funding to conduct psychopharmacology science. Thanks - we're all in this together!

Mark Greenwald, Ph.D. (President-Elect)
Professor and Director, Substance Abuse Research Division
Dept. of Psychiatry and Behavioral Neurosciences
Wayne State University School of Medicine
Detroit, Michigan
________________________________________
From: FASEB E-Action List [opa@faseb.org]
Sent: Wednesday, December 01, 2010 4:27 PM
To: Greenwald, Mark
Subject: Act Now! Urge Congress to Preserve the $1 Billion Increase for NIH!

Dear Colleague,

We need your help to encourage the U.S. Congress to finish work on the fiscal year (FY) 2011 budget for the National Institutes of Health (NIH) and the other federal science agencies which are currently operating under a temporary funding measure known as a "continuing resolution." This summer the House and Senate Appropriations Committees recommended that NIH receive $32 billion in 2011 – a $1 billion increase over current funding. In order for this increase to become law, Congress will need to pass an omnibus spending measure this month.

Please go to http://capwiz.com/faseb/issues/alert/?alertid=20222501 and email your Senators and Representative today. Urge them to make the $1 billion increase for NIH a reality by approving an FY 2011 omnibus funding bill. Please help ensure that funding for NIH remains a high priority for Congress.

Sincerely,
[cid:212an$IN288012912388310@eezzeldin-7410]
William T. Talman, MD
FASEB President

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org